Sign Up to like & get
recommendations!
1
Published in 2020 at "Annals of the American Thoracic Society"
DOI: 10.1513/annalsats.201912-915oc
Abstract: RATIONALE There is uncertainty on the optimal first-line therapy for symptomatic COPD. Long-acting beta-2-receptor agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) have long been mainstays of treatment, though it is still not clear if dual…
read more here.
Keywords:
laba lama;
therapy;
lama;
lama monotherapy ... See more keywords